|
|
Post by majorwood on Nov 17, 2020 23:02:24 GMT -5
|
|
|
|
Post by longliner on Nov 17, 2020 23:26:03 GMT -5
|
|
|
|
Post by rfogel on Nov 18, 2020 8:58:04 GMT -5
They're only just now getting a schedule 1 research license? Isn't that them basically admitting that they haven't yet even started doing any cannabis research?
|
|
|
|
Post by cjm18 on Nov 18, 2020 9:49:27 GMT -5
Not good enough news for a run.
|
|
|
|
Post by matt on Nov 18, 2020 11:34:03 GMT -5
They're only just now getting a schedule 1 research license? Isn't that them basically admitting that they haven't yet even started doing any cannabis research? Certainly you need an exemption from Schedule 1 to grow, possess, or do research on a drug under federal law. You can obtain cannabis in some states, the conditions for which vary by jurisdiction, so RLS could have been doing a limited amount of research with materials produced under state law, but only because the federal agencies decided to let them (whether the state allows it or not, cannabis is per se illegal under federal law). So no, this is not an admission that they have done nothing but it is an admission that RLS was not in a position to do any serious research going forward. To do any serious research requires the cooperation of various federal agencies, including FDA, and none of that will be forthcoming without first having a DEA license. In particular, no drug is going to be approved for animal or human use without undergoing multisite clinical trials, and those are extremely difficult to do without shipping experimental product across state lines. FDA always jumps in to regulate any activity involving the mere hint of interstate commerce as they have no ability to regulate certain activities that do not involve interstate commerce (like compounding pharmacies licensed by a state). A company can play games with the federal alphabet agencies and hope they continue to get away with it, or the company can step up and follow the rules thereby establishing themselves as a legitimate player doing serious work. It is never easy to become FDA's friend, but it is very easy to become their enemy. Getting a DEA license was the responsible thing to do, a license avoids regulatory "surprises" down the road, and overall this license must be considered a positive step forward. |
|
|
|
Post by goyocafe on Nov 18, 2020 11:43:29 GMT -5
I have to wonder what justification the DEA requires to grant such a license. It seems the bar is set quite high, or there wouldn’t be so much effort to work around them, and if this is the case I have to be encouraged that RLS was able to satisfy those requirements.
|
|
